Tag: stage

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 7, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.^2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),²and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).⁴ Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.^5,6

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

MONROE, N.J. and RANCHO CUCAMONGA, Calif., June 7, 2026 /PRNewswire/ -- For 12 years, MimiSilk, the at-home beauty device brand, has remained committed to a single...

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

MONROE, N.J. and RANCHO CUCAMONGA, Calif., June 7, 2026 /PRNewswire/ -- For 12 years, MimiSilk, the at-home beauty device brand, has remained committed to a single...

IBA‑UIBC Cup of Bakers 2027 “Golden Statue Cup” China Selection – Hong Kong & Macao SAR Selection Competition Successfully Held in Hong Kong

Competition Highlights Industry Excellence and Strengthens International Exchange in the Baking Sector HONG KONG, June 7, 2026 /PRNewswire/ -- The Final of the IBA‑UIBC Cup...

MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions

ZURICH, June 07, 2026 (GLOBE NEWSWIRE) -- The cryptocurrency market is witnessing a massive convergence of artificial intelligence and digital culture. Investors are shifting capital toward functional crypto ecosystems. Memecoins have evolved far beyond basic internet jokes.

Indonesian Firms Confront 18.9% Cost Surge as APAC Supply Chains Pivot to AI and Predictability

JAKARTA, Indonesia, June 7, 2026 /PRNewswire/ -- Indonesian retail and logistics sectors are aggressively restructuring supply chains following a major report revealing an 18.9%...

Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000

MONACO, June 06, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after the project announced that its presale has passed 9,300 holders ahead of its planned Q2 2026 exchange debut. The presale has continued to gather pace through Stage 17 at $0.01858, with AlphaSwap demo traction, instant token delivery, and a completed 10/10 BlockSAFU security audit supporting the project’s pre-listing profile.

The American Diabetes Association Announces Winners of the Innovation Challenge

NEW ORLEANS, June 6, 2026 /PRNewswire/ -- Today, from the main stage at the organization's 2026 Scientific Sessions, the American Diabetes Association® (ADA) announced...

Communiqué Orange : Orange signs a joint agreement to acquire SFR, a decisive step that will reinforce its leadership in France

Press release
Paris, 6 June 2026

Communiqué Orange : Signing of a Memorandum of Understanding for the acquisition of SFR

Press release
Paris, 6 June 2026

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsStage

Canadian Employers Invited to Create 10,000 New Opportunities Through National Inclusive Hiring Campaign

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Tag: stage

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

IBA‑UIBC Cup of Bakers 2027 “Golden Statue Cup” China Selection – Hong Kong & Macao SAR Selection Competition Successfully Held in Hong Kong

MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions

Indonesian Firms Confront 18.9% Cost Surge as APAC Supply Chains Pivot to AI and Predictability

Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000

The American Diabetes Association Announces Winners of the Innovation Challenge

Communiqué Orange : Orange signs a joint agreement to acquire SFR, a decisive step that will reinforce its leadership in France

Communiqué Orange : Signing of a Memorandum of Understanding for the acquisition of SFR

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us